Insights

We’re acknowledged for our strong market insight and technical know-how

Life sciences
Insights

The National Security and Investment Act – a year on

2 February 2023
Read more
Insights

Penningtons Manches Cooper acts for SkinBioTherapeutics plc on placing and REX retail offer on AIM

5 January 2023
Read more
Insights

The Moderna v Pfizer-Biontech COVID-19 vaccine dispute: a brief explanation

30 November 2022
Read more
Insights

Same old, same old but different: the proposed UK framework for medical device regulations

21 November 2022
Read more
News

Penningtons Manches Cooper advises Seloxium on its spin-out from Oxford University

7 November 2022
Read more
Insights

Patents to biological medicines in combination: is two really better than one?

23 September 2022
Read more
Insights

The UK moves into the fast lane for biosimilar regulatory approvals

29 July 2022
Read more
News

Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures

12 July 2022
Read more
Insights

The In Vitro Diagnostic Medical Devices Regulation is here — a closer look at what you need to know

6 July 2022
Read more
News

Penningtons Manches Cooper advises US company Echo Healthcare on its cross-border acquisition of Immersive Interactive

17 June 2022
Read more
Insights

Comparing the EU clinical trials regulation and the MHRA consultation on clinical trials

23 May 2022
Read more
Insights

Clinical trial management agreements with CROs: Cardiorentis AG v IQVIA Limited

19 May 2022
Read more
Back to Life sciences